nsc 664704 has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackeifi, CA; Arvanites, AC; Cerqueira, A; Davidow, LS; Gupta, SK; Kim, KJ; Ngo, HD; Powers, BE; Rosowski, KA; Rubin, LL; Schein, PA; Wainger, BJ; Woolf, CJ; Yang, YM | 1 |
1 other study(ies) available for nsc 664704 and ALS - Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.
Topics: Amyotrophic Lateral Sclerosis; Animals; Benzazepines; Cell Differentiation; Cell Survival; Cells, Cultured; Cholestenones; Embryonic Stem Cells; Glycogen Synthase Kinase 3; Humans; Indoles; Induced Pluripotent Stem Cells; Intracellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Motor Neurons; Mutation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Structure-Activity Relationship; Superoxide Dismutase; Superoxide Dismutase-1 | 2013 |